PiISCATAWAY, N.J. — Camber Pharmaceuticals has added gabapentin tablets (generic for Gralise) to its portfolio. Camber already offers gabapentin tablets and capsules (generic for Neurontin). Generics for Gralise and Neurontin are not interchangeable. Gabapentin tablets (generic for Gralise) are indicated for the management of postherpetic neuralgia (PHN). Gabapentin tablets (generic for Gralise) 300 mg and
PISCATAWAY, N.J. — Camber Pharmaceuticals has added memantine HCl Tablets to its portfolio. The generic version of Namenda is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine HCl tablets are available in 5 and 10 mg strengths and supplied in 60-count bottles. More information about memantine HCl Tablets can
PISCATAWAY, N.J. – Camber Pharmaceuticals recently announced the addition of naproxen oral suspension to its current portfolio. Naproxen oral suspension is indicated for the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis tendonitis bursitis acute gout The management of: pain primary dysmenorrhea Naproxen oral suspension from Camber
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of Lamotrigine ER Tablets to its current portfolio. Lamotrigine ER Tablets are indicated as adjunctive therapy for primary generalized tonic-clonic (PGTC) seizures and partial- onset seizures with or without secondary generalization in patients aged 13 years and older. Lamotrigine ER Tablets from Camber are available in 25, 50,
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of dabigatran etexilate capsules to its current portfolio. Dabigatran etexilate capsules are a direct thrombin inhibitor, indicated to reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation. Dabigatran etexilate capsules from Camber are available in 75 and 150 mg strengths
PISCATAWAY, N.J.– Camber Pharmaceuticals announced the addition of Pirfenidone Tablets to its current portfolio. Pirfenidone Tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pirfenidone Tablets from Camber are available in two strengths: 267 mg in 3 pack/ 90 count bottles (270 count total) 801 mg strength in 90 count bottles
Piscataway, N.J. – Camber Pharmaceuticals has announced the addition of roflumilast tablets to its current portfolio. Roflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis. Roflumilast tablets from Camber are available in 500 mcg strength in 30 and 90 count bottles.
PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of acyclovir oral suspension to its current portfolio. Acyclovir oral suspension is a synthetic nucleoside analogue active against herpes viruses. Acyclovir oral suspension from Camber is available in 200 mg/5 mL strength in 473 mL bottles.
PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of solifenacin succinate tablets to its current portfolio. Solifenacin succinate tablets are used to treat symptoms of overactive bladder, such as frequent or urgent urination, and incontinence (urine leakage). Solifenacin succinate tablets from Camber are available in 5 mg and 10 mg strengths. Both strengths are available
PISCATAWAY, N.J – Camber Pharmaceuticals has added tolvaptan 15 mg tablets to their current portfolio, which is the generic version of Samsca. Tolvaptan 15 mg tablets are used to treat hyponatremia (low levels of sodium in your blood) in people with heart failure, and certain hormonal imbalances. Tolvaptan 15 mg tablets from Camber are available
PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of emtricitabine and tenofovir disoproxil fumarate tablets to their current portfolio. Emtricitabine and tenofovir disoproxil fumarate tablets is a two-drug combination of emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated in combination with other antiretroviral agents for the treatment of HIV-1
PISCATAWAY, N.J.– Camber Pharmaceuticals announces the addition of efavirenz, emtricitabine and eenofovir disoproxil fumarate tablets to their current portfolio. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 88 lbs. Efavirenz, Emtricitabine and
PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of atazanavir capsules to their current portfolio. Atazanavir capsules are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 33 lbs. Atazanavir capsules from Camber are available in 150 mg and 200 mg-
PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of fosaprepitant for injection to their current portfolio. Fosaprepitant for injection is indicated in adults for the prevention of: • acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. • delayed nausea and vomiting associated with initial
